COVID-19 caused millions of missed cancer screenings; how will oncology community respond?

Although much remains unknown about the impact of COVID-19 on people with cancer, the impact on screening is becoming clearer.
A growing body of data estimates the pandemic resulted in 22 million missed or canceled cancer screenings in the United States in just a 4-month period in 2020.
This has led to an increase in the diagnosis of later-stage cancer cases that typically require more complex care.
A study from American Cancer Society — performed within 32 community health centers that serve lower-income populations — showed that screening mammograms dropped by 8% among women aged

Although much remains unknown about the impact of COVID-19 on people with cancer, the impact on screening is becoming clearer.
A growing body of data estimates the pandemic resulted in 22 million missed or canceled cancer screenings in the United States in just a 4-month period in 2020.
This has led to an increase in the diagnosis of later-stage cancer cases that typically require more complex care.
A study from American Cancer Society — performed within 32 community health centers that serve lower-income populations — showed that screening mammograms dropped by 8% among women aged